Cargando…
Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography
Diagnosis of pancreatic ductal adenocarcinoma (PDAC) by current imaging techniques is useful and widely used in the clinic but presents several limitations and challenges, especially in small lesions that frequently cause radiological tumors infra-staging, false-positive diagnosis of metastatic tumo...
Autores principales: | González-Gómez, Ruth, Pazo-Cid, Roberto A., Sarría, Luis, Morcillo, Miguel Ángel, Schuhmacher, Alberto J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000738/ https://www.ncbi.nlm.nih.gov/pubmed/33801810 http://dx.doi.org/10.3390/jcm10061151 |
Ejemplares similares
-
Diagnosis of Glioblastoma by Immuno-Positron Emission Tomography
por: Ruiz-López, Eduardo, et al.
Publicado: (2021) -
Molecular Targeted Positron Emission Tomography Imaging and Radionuclide Therapy of Pancreatic Ductal Adenocarcinoma
por: Poels, Thomas T., et al.
Publicado: (2021) -
Simultaneous Photoradiochemical Labeling of Antibodies for Immuno-Positron Emission Tomography
por: Patra, Malay, et al.
Publicado: (2019) -
Usefulness of (18)F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma
por: Yokose, Takahiro, et al.
Publicado: (2020) -
Use of (18)F-2-Fluorodeoxyglucose
to Label Antibody Fragments for Immuno-Positron Emission Tomography
of Pancreatic Cancer
por: Rashidian, Mohammad, et al.
Publicado: (2015)